← back to search

Hui-Qiang Huang

Sun Yat-sen University · CN
Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, CNS Lymphoma Diagnosis and Treatment, and Viral-associated cancers and disorders.
h-index
6
citations
413
works
10
NIH funding
primary concept
email

Recent publications

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Blood Advances 2020cited by 57position: middledoi
A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study
Leukemia 2020cited by 36position: middledoi
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Leukemia 2020cited by 31position: middledoi
Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma
Leukemia 2019cited by 71position: middledoi
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
The Lancet Oncology 2018cited by 217position: middledoi
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
Leukemia 2018cited by 126position: middledoi
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
Journal of Hematology & Oncology 2016cited by 290position: middledoi
Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator
Cancer Immunology Immunotherapy 2015cited by 101position: middledoi
CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type
Annals of Hematology 2015cited by 95position: middledoi
MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16
Clinical Cancer Research 2015cited by 85position: middledoi
Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
PLoS ONE 2012cited by 147position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yu Jing Zhang · Shenyang Pharmaceutical University2 papers (2015–2016)Yi‐Xin Zeng · Sun Yat-sen University2 papers (2015–2018)Liang Wang · Beijing Tongren Hospital2 papers (2015–2016)Yi Xia · Sun Yat-sen University2 papers (2012–2018)Zhong-Jun Xia · Sun Yat-sen University Cancer Center2 papers (2015–2016)Wen-Qi Jiang · Sun Yat-sen University2 papers (2012–2016)Ying-Jie Zhu · Sun Yat-sen University1 papers (2012–2012)Qing-Qing Cai · Sun Yat-sen University1 papers (2018–2018)Ya-Jun Li · Central South University1 papers (2012–2012)Haixia Deng · Chongqing Medical University1 papers (2015–2015)Xiao‐Jun Xia · Sun Yat-sen University1 papers (2018–2018)Jia-Jia Huang · Minzu University of China1 papers (2012–2012)Xi-Wen Bi · Sun Yat-sen University1 papers (2016–2016)Jing-Xian Shen · Sun Yat-sen University1 papers (2018–2018)Qing Liu · Mongolian University of Science and Technology1 papers (2018–2018)Chunyan Lan · Nanchang University1 papers (2018–2018)Zhiyong Yuan · Qingdao University1 papers (2015–2015)Jing Hui Wang · Sun Yat-sen University1 papers (2016–2016)Suying Lü · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2015–2015)Zhiming Li · Xinjiang Medical University1 papers (2012–2012)